Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

3(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

83%

Ph phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(3)

Detailed Status

Completed3

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (16.7%)

N/A5 (83.3%)

Trials by Status

completed350%

recruiting350%

Recent Activity

3 active trials

Showing 5 of 6

recruitingnot_applicable

Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides

NCT01173042

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07244458Not Applicable

Dietary Peanuts and Nutrition-Related Outcomes

Recruiting

NCT07531849Not Applicable

Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas

Recruiting

NCT06867198Not Applicable

Peanuts for Cardiometabolic, Brain, and Intestinal Health

Recruiting

NCT05532007Not Applicable

Effects of Peanut Intake on Cognitive Functions

Completed

NCT01173042Phase 1

Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides

Completed

NCT00857402Not Applicable

Arginine as an Adjuvant Treatment Against Tuberculosis

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6